Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. May 21, 2025; 31(19): 105283
Published online May 21, 2025. doi: 10.3748/wjg.v31.i19.105283
Table 1 Baseline characteristics of patients with and without anastomotic leakage, n (%)

NAL (n = 1732)
AL (n = 86)
P value
Sex = male1055 (60.9)64 (74.4)0.016
Tobacco or alcohol< 0.001
    No1256 (72.5)46 (53.5)
    Tobacco258 (14.9)18 (20.9)
    Alcohol25 (1.4)1 (1.2)
    All193 (11.1)21 (24.4)
T stage< 0.001
    T1192 (11.1)2 (2.3)
    T2453 (26.2)17 (19.8)
    T3995 (57.4)43 (50.0)
    T492 (5.3)24 (27.9)
N stage0.025
    N0291 (16.8)12 (14.0)
    N11260 (72.7)57 (66.3)
    N2181 (10.5)17 (19.8)
Histological type< 0.001
    Adenocarcinoma36 (2.1)0 (0.0)
    Adenosquamouscarcinoma0 (0.0)6 (7.0)
    Others1663 (96.0)80 (93.0)
    Multi1 (0.1)0 (0.0)
    Neuroendocrine17 (1.0)0 (0.0)
    Stromal15 (0.9)0 (0.0)
Family = yes32 (1.8)10 (11.6)< 0.001
CD34 = yes647 (37.4)67 (77.9)< 0.001
FOBT = M11276 (73.7)64 (74.4)0.978
Location = others76 (4.4)2 (2.3)0.517
Age = high871 (50.3)39 (45.3)0.433
Neoadjuvant = yes142 (8.2)57 (66.3)< 0.001